Korth R, Nunez D, Bidault J, Benveniste J
INSERM U 200, Université Paris-Sud, Clamart, France.
Eur J Pharmacol. 1988 Jul 26;152(1-2):101-10. doi: 10.1016/0014-2999(88)90840-0.
The aggregation of washed human platelets with paf-acether (paf) and [3H]paf binding were inhibited in a concentration- and time-dependent manner by three chemically defined ginkgolides (BN 52020, BN 52021, BN 52022) and their mixture, BN 52063 (molar ratio: 2:2:1). The IC50 values for aggregation correlated well with the IC50 values for [3H]paf binding (R-square 0.971). BN 52021, BN 52020 and BN 52063 (6 microM), as well as unlabelled paf (50 nM), displaced platelet-bound [3H]paf. Specific binding (total minus non-specific binding) in the presence of BN 52020 and BN 52063 was saturated but that observed in the presence of BN 52022 was not. However all ginkgolides shifted the dose-dependent paf-induced platelet aggregation curve rightwards. BN 52063 failed to modulate paf metabolism either in plasma or in the presence of platelets. The present results suggest that the ginkgolide mixture, BN 52063, acts at the paf binding level and the close correlation between ginkgolide effects on aggregation vs. paf binding illustrates the functional relevance of the putative paf platelet receptor.
三种化学结构明确的银杏内酯(BN 52020、BN 52021、BN 52022)及其混合物BN 52063(摩尔比为2:2:1)以浓度和时间依赖性方式抑制洗涤后的人血小板与血小板活化因子(PAF)的聚集以及[3H]PAF结合。聚集的IC50值与[3H]PAF结合的IC50值密切相关(决定系数R²为0.971)。BN 52021、BN 52020和BN 52063(6微摩尔)以及未标记的PAF(50纳摩尔)可置换血小板结合的[3H]PAF。在BN 52020和BN 52063存在下的特异性结合(总结合减去非特异性结合)呈饱和状态,但在BN 52022存在下观察到的情况并非如此。然而,所有银杏内酯均使剂量依赖性PAF诱导的血小板聚集曲线右移。BN 52063在血浆中或有血小板存在时均未能调节PAF代谢。目前的结果表明,银杏内酯混合物BN 52063作用于PAF结合水平,银杏内酯对聚集和PAF结合的影响之间的密切相关性说明了假定的PAF血小板受体的功能相关性。